Mitochondrion

Mitochondrion is a peer-reviewed international research journal on the biology of mitochondria, published by Elsevier since 2001 as the official journal of the Mitochondria Research Society, issued bimonthly, with a 2025 Journal Impact Factor of 5.7.《线粒体》（Mitochondrion）是一本线粒体生物学领域的国际同行评审期刊，2001 年起由（Elsevier）出版，为（Mitochondria Research Society）会刊，双月刊，2025 年期刊影响因子为 5.7。

Scope

• The scope is deliberately broad, reporting the basic science of mitochondria from all organisms, from basic research through to the pathology and clinical aspects of mitochondrial diseases.刊物范围刻意求宽，报道所有生物体线粒体的基础科学，自基础研究一直延伸到线粒体疾病的病理学与临床方面。
• Original contributions are welcomed from evolution, biophysics, biochemistry, molecular and cell biology, genetics, pharmacology, toxicology, forensic science, programmed cell death, aging and cancer researchers.刊物欢迎进化、生物物理、生物化学、分子与细胞生物学、遗传学、药理学、毒理学、法医学、程序性细胞死亡、衰老与癌症等分支学科研究者投稿。
• Research articles and reviews form the core, alongside fast-track papers that are refereed rapidly and published generally within ten weeks, and correspondence on matters of interest to mitochondria researchers.研究论文与综述为主体，另有快速评审通道稿件，一般十周内即可发表，以及面向线粒体研究者的通信类文章。
• Editorial formats include MitoMatters, Profiles and Perspectives, The Mito Mew, invited book reviews, and an announcements and calendar section.社论类栏目包括（MitoMatters）、（Profiles and Perspectives）、（The Mito Mew）、邀约书评以及会议与动态通告。
• The journal is the official organ of the Mitochondria Research Society and is affiliated with the Japanese Society of Mitochondria Research and Medicine.本刊为（Mitochondria Research Society）官方会刊，并与（Japanese Society of Mitochondria Research and Medicine）建立隶属关系。
• Indexing covers the Science Citation Index Expanded, MEDLINE, PubMed and Scopus, with MEDLINE coverage beginning at volume 5 in February 2005.刊物被（SCIE）、（MEDLINE）、（PubMed）与（Scopus）收录，（MEDLINE）收录自 2005 年 2 月第 5 卷第 1 期起。
• Clinical and translational work on mitochondrial disorders sits alongside basic mitochondrial genetics and bioenergetics within the same pages.线粒体疾病的临床与转化研究与基础线粒体遗传学、生物能学研究同刊并载。

History

• Elsevier launched the title in 2001, with volume 1 preceded by an introductory information issue dated November 2000, according to the NLM catalog record.据（NLM）目录著录，本刊由（Elsevier）于 2001 年创办，第 1 卷之前另有一期 2000 年 11 月的信息试刊。
• Keshav Singh of the University of Alabama at Birmingham is listed as founding editor and still serves as editor-in-chief.（University of Alabama at Birmingham）的（Keshav Singh）为创刊编辑，至今仍担任主编。
• The journal has been the official journal of the Mitochondria Research Society since its launch, linking the society to a dedicated publishing venue.本刊自创刊即为（Mitochondria Research Society）会刊，为该学会提供了专属的出版阵地。
• Publication is bimonthly with six issues a year, and from 2014 each issue has carried its own volume number, reaching volumes 80 to 85 in 2025 and 86 to 91 in 2026.刊物为双月刊，年出 6 期，自 2014 年起每期单独编卷，2025 年已出至第 80 至 85 卷，2026 年至第 86 至 91 卷。
• The publishing model is hybrid, with an open-access article charge of USD 3,730 excluding taxes and no fee for authors who choose the subscription route.出版模式为混合式，开放获取文章收费 3,730 美元（不含税），选择订阅路径的作者无需付费。
• The 2025 Journal Impact Factor is 5.7 and CiteScore stands at 8.9, with the journal placed Q1 in genetics and heredity and Q2 in cell biology.2025 年期刊影响因子为 5.7，（CiteScore）为 8.9，在遗传学类别居一区、细胞生物学类别居二区。

Editors

• Keshav Singh, professor at the University of Alabama at Birmingham, leads the journal as editor-in-chief, with research spanning mitochondrial genetics, cancer and health equity.（University of Alabama at Birmingham）教授（Keshav Singh）任主编，研究涉及线粒体遗传学、癌症与健康公平。
• Five associate editors support him: Mariana Gerschenson at the University of Hawaii, Russell Saneto at Seattle Children's Research Institute, A Phillip West at the Jackson Laboratory, Yau-Huei Wei at Changhua Christian Hospital and Gokhan Kubat at Baskent University.五位副主编辅佐：（University of Hawaii）的（Mariana Gerschenson）、（Seattle Children's Research Institute）的（Russell Saneto）、（Jackson Laboratory）的（A Phillip West）、（Changhua Christian Hospital）的（Yau-Huei Wei）与（Baskent University）的（Gokhan Kubat）。
• The editorial board lists more than forty members, with strong representation from the United States alongside Japan, the United Kingdom, the Netherlands, Israel, Denmark, Australia, Portugal, Italy, Brazil, Switzerland, Canada, India, Sweden, China, Taiwan and Turkey.编委会列名成员超过四十人，以美国为主，日本、英国、荷兰、以色列、丹麦、澳大利亚、葡萄牙、意大利、巴西、瑞士、加拿大、印度、瑞典、中国、台湾与土耳其均有席位。
• Board figures include Douglas Wallace of the Children's Hospital of Philadelphia, Patrick Chinnery of Newcastle University, Vilhelm Bohr of the National Institute on Aging and Carlos Moraes of the University of Miami.编委中包括（Children's Hospital of Philadelphia）的（Douglas Wallace）、（Newcastle University）的（Patrick Chinnery）、（National Institute on Aging）的（Vilhelm Bohr）与（University of Miami）的（Carlos Moraes）。
• Elsevier journal insights report 130 days from submission to acceptance, two days from acceptance to online publication and an acceptance rate of 12 percent.（Elsevier）期刊洞察数据显示，投稿至录用平均 130 天，录用至在线发表 2 天，录用率为 12%。
• Submissions run through the Editorial Manager site under the journal code MITOCH.投稿经（Editorial Manager）平台进行，期刊代码为（MITOCH）。